Global Microarray Analysis Market—Forecast till 2027

$4,450$6,250

The global microarray analysis market is anticipated to reach USD 6,607.64 million by 2027 to witness a healthy  CAGR of 7.76%.

Clear

Description

Global Microarray Analysis Market: By Product& Services (Consumables, Software and Services, Others), By Type (DNA Microarrays, Protein Microarrays), By Application (Drug discovery, Disease Diagnostic, Research Applications), By End User (Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories), and by Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2027

Market Review
The microarray analysis market is anticipated to reach USD 6,607.64 million by 2027 to witness a healthy CAGR of 7.76%. Microarray is an incredible methodology used to examine quality articulation for different trial purposes. Various microarray stages are accessible for testing. The advancement of microarrays had worked on the aftereffects of hereditary testing. The worldwide microarrays investigation market is significantly determined by the high pervasiveness of malignancy and the rising requirement for research in drug enterprises. However, the Presence of substitutes and lack of skilled professionals are expected to restrain the global market growth during the review period.
The expanding commonness of various ongoing sicknesses, utilization of this procedure to analyze irresistible illnesses, improvement in the field of hereditary qualities, and expanding medical care consumption have given a push to the market. The growth of the global market is attributed to the increasing application area of microarrays, the increasing prevalence of cancer, and Funding for genomic and proteomic research. Nevertheless, the significant expense of tests and the requirement for innovative instruments might control the development of the microarray investigation market.
Market Segmentation
The global Microarrays market has been classified into Product & Services, type, and application.
In terms of products and services, the global market has been divided into Consumables, Software and Services, and Instruments.
By Type segment, the global market is categorized into DNA Microarrays, Protein Microarrays, and others.
Based on Application the market has been classified into Drug Discovery, Disease Diagnostics, Research Applications, and Others

Global Microarray Analysis Market, based on End User has been classified into Research Academic Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Others
Regional Analysis
The global microarray analysis market, in terms of region, has been studied across the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
In 2019, the Americas represented the biggest portion of the overall industry of 40.98% and were assessed to overwhelm the worldwide microarray investigation market all through the estimated time frame. This biggest portion of the overall industry can be credited to the expanding reception of new advances and the presence of a key part in the district. The Americas is additionally ordered into North America and Latin America.

Europe holds a sound offer in the worldwide microarray examination market and is the second-biggest market after the Americas, attributable to the exceptionally created medical care industry, conspicuous exploration and improvement framework, and availability of items.

The microarray investigation market in Asia-Pacific is divided into China, Japan, India, the Republic of Korea, Australia, and the Rest of Asia-Pacific. This territorial market is expected to be the second quickest developing market.
Major players
The major Companies Covered in Microarray Analysis Market Report are Agilent Technologies (US), Bio-Rad Laboratories (US), Illumina (US), Thermo Fisher Scientific (US), Microarrays, Inc. (US), PerkinElmer, Inc. (US), Merck KGaA (Germany), GE Healthcare (US), Danaher Corporation (US), and Arrayit Corporation (US).

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 GROWING APPLICATION AREAS OF MICROARRAYS

4.2.2 INCREASING INCIDENCE OF CANCER

4.2.3 FUNDING FOR GENOMIC AND PROTEOMIC RESEARCH

4.3 RESTRAINTS

4.3.1 PRESENCE OF SUBSTITUTES AND LACK OF SKILLED PROFESSIONALS

4.4 OPPORTUNITIES

4.4.1 NEW PRODUCT LAUNCH IN DEVELOPING MARKETS

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 BARGAINING POWER OF SUPPLIERS

5.2.2 BARGAINING POWER OF BUYERS

5.2.3 THREAT OF NEW ENTRANTS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE MICROARRAY ANALYSIS MARKET

5.3.1 OVERVIEW

5.3.2 IMPACT ON SUPPLY CHAIN

5.3.3 IMPACT ON DEVELOPMENT OF NEW MICROARRAY PRODUCTS FOR MAPPING COVID-19

6 GLOBAL MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICES

6.1 OVERVIEW

6.2 CONSUMABLES

6.3 SOFTWARE AND SERVICES

6.4 INSTRUMENTS

7 GLOBAL MICROARRAY ANALYSIS MARKET, BY TYPE

7.1 OVERVIEW

7.2 DNA MICROARRAYS

7.3 PROTEIN MICROARRAYS

7.4 OTHERS

8 GLOBAL MICROARRAY ANALYSIS MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 DRUG DISCOVERY

8.3 DISEASE DIAGNOSTICS

8.4 RESEARCH APPLICATIONS

8.5 OTHERS

9 GLOBAL MICROARRAY ANALYSIS MARKET, BY END USERS

9.1 OVERVIEW

9.2 RESEARCH & ACADEMIC INSTITUTES

9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

9.4 DIAGNOSTIC LABORATORIES

9.5 OTHERS

10 GLOBAL MICROARRAY ANALYSIS MARKET, BY REGION

10.1 OVERVIEW

10.2 AMERICAS

10.2.1 NORTH AMERICA

10.2.1.1 U.S.

10.2.1.2 CANADA

10.2.2 LATIN AMERICA

10.3 EUROPE

10.3.1 WESTERN EUROPE

10.3.1.1 GERMANY

10.3.1.2 FRANCE

10.3.1.3 UK

10.3.1.4 ITALY

10.3.1.5 SPAIN

10.3.1.6 REST OF WESTERN EUROPE

10.3.2 EASTERN EUROPE

10.4 ASIA-PACIFIC

10.4.1 CHINA

10.4.2 INDIA

10.4.3 JAPAN

10.4.4 SOUTH KOREA

10.4.5 AUSTRALIA

10.4.6 REST OF ASIA-PACIFIC

10.5 MIDDLE EAST & AFRICA

10.5.1 MIDDLE EAST

10.5.2 AFRICA

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW

11.2 MARKET SHARE ANALYSIS

11.3 COMPETITIVE BENCHMARKING

11.4 MAJOR GROWTH STRATEGY IN THE GLOBAL MICROARRAY ANALYSIS MARKET

11.5 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL MICROARRAY MARKET

11.6 KEY DEVELOPMENT ANALYSIS

11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES

11.7.1 PRODUCT LAUNCHES/PRODUCT APPROVALS

11.7.2 PARTNERSHIPS/AGREEMENTS

11.7.3 ACQUISITIONS

11.7.4 EXPANSIONS

12 COMPANY PROFILES

12.1 THERMO FISHER SCIENTIFIC INC.

12.1.1 COMPANY OVERVIEW

12.1.2 FINANCIAL OVERVIEW

12.1.3 PRODUCTS/SERVICES OFFERED

12.1.4 KEY DEVELOPMENTS

12.1.5 SWOT ANALYSIS

12.1.6 KEY STRATEGIES

12.2 AGILENT TECHNOLOGIES

12.2.1 COMPANY OVERVIEW

12.2.2 FINANCIAL OVERVIEW

12.2.3 PRODUCTS/SERVICES OFFERED

12.2.4 KEY DEVELOPMENTS

12.2.5 SWOT ANALYSIS

12.2.6 KEY STRATEGIES

12.3 ILLUMINA

12.3.1 COMPANY OVERVIEW

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCTS/SERVICES OFFERED

12.3.4 KEY DEVELOPMENTS

12.3.5 SWOT ANALYSIS

12.3.6 KEY STRATEGIES

12.4 PERKINELMER, INC

12.4.1 COMPANY OVERVIEW

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS/SERVICES OFFERED

12.4.4 KEY DEVELOPMENTS

12.4.5 SWOT ANALYSIS

12.4.6 KEY STRATEGIES

12.5 MERCK KGAA

12.5.1 COMPANY OVERVIEW

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS/SERVICES OFFERED

12.5.4 KEY DEVELOPMENTS

12.5.5 SWOT ANALYSIS

12.5.6 KEY STRATEGIES

12.6 GE HEALTHCARE

12.6.1 COMPANY OVERVIEW

12.6.2 FINANCIAL OVERVIEW

12.6.3 PRODUCTS/SERVICES OFFERED

12.6.4 KEY DEVELOPMENTS

12.6.5 SWOT ANALYSIS

12.6.6 KEY STRATEGIES

12.7 DANAHER CORPORATION

12.7.1 COMPANY OVERVIEW

12.7.2 FINANCIAL OVERVIEW

12.7.3 PRODUCTS/SERVICES OFFERED

12.7.4 KEY DEVELOPMENTS

12.7.5 SWOT ANALYSIS

12.7.6 KEY STRATEGIES

12.8 ARRAYIT CORPORATION

12.8.1 COMPANY OVERVIEW

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS/SERVICES OFFERED

12.8.4 KEY DEVELOPMENTS

12.8.5 SWOT ANALYSIS

12.8.6 KEY STRATEGIES

12.9 BIO-RAD LABORATORIES

12.9.1 COMPANY OVERVIEW

12.9.2 FINANCIAL OVERVIEW

12.9.3 PRODUCTS/SERVICES OFFERED

12.9.4 KEY DEVELOPMENTS

12.9.5 SWOT ANALYSIS

12.9.6 KEY STRATEGIES

12.10 MICROARRAYS INC.

12.10.1 COMPANY OVERVIEW

12.10.2 FINANCIAL OVERVIEW

12.10.3 PRODUCTS/SERVICES OFFERED

12.10.4 KEY DEVELOPMENTS

12.10.5 SWOT ANALYSIS

12.10.6 KEY STRATEGIES

13 APPENDIX

13.1 REFERENCES

13.2 RELATED REPORTS